FindTrial
Sign In

Clinical Pharmacist Support for Early Detection and Better Care of PCOS in Women

Clinical pharmacist led approaches for early symptom recognition and management of polycystic ovarian syndrome (PCOS) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100583
Enrollment
353
Registered
2026-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Clinical pharmacist intervention: Clinical pharmacist led approaches on early symptom recognition and management of polycystic ovarian syndrome for six months Intervention2: Nil: Six mo

Sponsors

SPrathusha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women of reproductive age. Women with symptoms of PCOS more than one. Women willing to participate and provide informed consent. Women attending outpatient gynaecology, endocrinology, or community health clinics.

Exclusion criteria

Exclusion criteria: Women who diagnosed with other endocrine disorders. Pregnant or lactating women. Women who are on hormonal therapy other than PCOS. Women unwilling or unable to provide informed consent.

Design outcomes

Primary

MeasureTime frame
To determine the clinical pharmacist led approaches in early symptom recognition and management of polycystic ovarian syndromeTimepoint: Baseline, 4 weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr T Rajavardhana

Balaji college of pharmacy

rajavardhana2@gmail.com9533260926

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026